Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study-Reference-Cited by-同舟云学术

Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study

Published:2017-11 Issue:11 Volume:5 Page:891-902
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Ahn Myung-Ju,Kim Dong-Wan,Cho Byoung Chul,Kim Sang-We,Lee Jong Seok,Ahn Jin-Seok,Kim Tae Min,Lin Chia-Chi,Kim Hye Ryun,John Thomas,Kao Steven,Goldman Jonathan W,Su Wu-Chou,Natale Ronald,Rabbie Sarit,Harrop Bryony,Overend Philip,Yang Zhenfan,Yang James Chih-Hsin

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference29 articles.

1. Gefitinib, response of erlotinib-refractory lung cancer involving meninges: role of EGFR mutation;Choong;Nat Clin Pract Oncol,2006

2. Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers;Rangachari;Lung Cancer,2015

3. Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, and neuroimaging features;Palma;Clin Neurol Neurosurg,2013

4. EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data;Fan;Onco Targets Ther,2014

5. Clinical outcome in patients with leptomeningeal metastasis from non-small-cell lung cancer: Okayama Lung Cancer Study Group;Umemura;Lung Cancer,2012

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Advances in Lung Cancer with Leptomeningeal Metastasis;Current Cancer Drug Targets;2024-09

2. The combination therapy using tyrosine kinase receptors inhibitors and repurposed drugs to target patient-derived glioblastoma stem cells;Biomedicine & Pharmacotherapy;2024-07

3. In silico transcriptome screens identify epidermal growth factor receptor inhibitors as therapeutics for noise-induced hearing loss;Science Advances;2024-06-21

4. Dose Optimization of Targeted Therapies for Oncologic Indications;Cancers;2024-06-09

5. Precise Molecular Subtyping Reveals Heterogeneity of Lung Adenocarcinoma Based on DNA Methylation;Current Medicinal Chemistry;2024-06-05